UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000001492
Receipt number R000001738
Scientific Title Pharmacogenetic study on the influence of aldehyde dehydrogenase 2 (ALDH2) gene polymorphism on the vasodilatation induced by organic nitrates
Date of disclosure of the study information 2008/11/11
Last modified on 2011/03/30 17:42:45

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Pharmacogenetic study on the influence of aldehyde dehydrogenase 2 (ALDH2) gene polymorphism on the vasodilatation induced by organic nitrates

Acronym

The influence of ALDH2 gene polymorphism on the effect of organic nitrates

Scientific Title

Pharmacogenetic study on the influence of aldehyde dehydrogenase 2 (ALDH2) gene polymorphism on the vasodilatation induced by organic nitrates

Scientific Title:Acronym

The influence of ALDH2 gene polymorphism on the effect of organic nitrates

Region

Japan


Condition

Condition

angina pectoris

Classification by specialty

Cardiology

Classification by malignancy

Others

Genomic information

YES


Objectives

Narrative objectives1

By clinical trials in healthy volunteers, we will determine the relation between genetic polymorphism of the type 2 aldehyde dehydrogenase and the vasodilator action of nitroglycerine and isosorbide dinitrate to personalize the treatment with organic nitrates.

Basic objectives2

Pharmacodynamics

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Explanatory

Developmental phase

Not applicable


Assessment

Primary outcomes

Ratio of maximal increase in brachial artery diameter
Time to attain maximal and 90% maximal dilatation of brachial artery

Key secondary outcomes

Pulse rate, blood pressure, and their post/pre-administration ratios


Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification

YES

Dynamic allocation

NO

Institution consideration

Institution is considered as a block.

Blocking

NO

Concealment

Numbered container method


Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Medicine

Interventions/Control_1

nitroglycerin

Interventions/Control_2

isosorbide dinitrate

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

39 years-old >

Gender

Male and Female

Key inclusion criteria

Older than 20 and younger than 39
Healthy volunteers
Persons whose ALDH2 gene polymorphism is known

Key exclusion criteria

History of cardiovascular diseases
Serious liver damages
Serious renal damages
Pregnant women
History of adverse reaction to organic nitrates
Persons using sildenafil, vardenafil, or tadalafil
Systolic blood pressure less than 90 mmHg
Body weight less than 40 kg or more than 90 kg
Persons considered to be unsuitable to the study

Target sample size

72


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Toshiyuki Sasaguri

Organization

Faculty of Medical Sciences, Kyushu University

Division name

Department of Clinical Pharmacology

Zip code


Address

3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan

TEL

092-642-6080

Email



Public contact

Name of contact person

1st name
Middle name
Last name Toshiyuki Sasaguri

Organization

Faculty of Medical Sciences, Kyushu University

Division name

Department of Clinical Pharmacology

Zip code


Address

3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan

TEL

092-642-6080

Homepage URL


Email

sasaguri@med.kyushu-u.ac.jp


Sponsor or person

Institute

Department of Clinical Pharmacology, Faculty of Medical Sciences, Kyushu University

Institute

Department

Personal name



Funding Source

Organization

Ministry of Education, Culture, Sports, Science and Technology

Organization

Division

Category of Funding Organization

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

九州大学病院(福岡県) Kyushu University Hospital, Fukuoka, Japan


Other administrative information

Date of disclosure of the study information

2008 Year 11 Month 11 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2008 Year 09 Month 12 Day

Date of IRB


Anticipated trial start date

2008 Year 12 Month 01 Day

Last follow-up date

2011 Year 03 Month 01 Day

Date of closure to data entry

2011 Year 03 Month 01 Day

Date trial data considered complete

2011 Year 03 Month 01 Day

Date analysis concluded

2012 Year 03 Month 01 Day


Other

Other related information



Management information

Registered date

2008 Year 11 Month 10 Day

Last modified on

2011 Year 03 Month 30 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000001738


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name